Pharmacists in Zephyr Cove, NV Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Daria Siedzinski Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Elks Point Rd, Zephyr Cove, NV 89448 Phone: 775-586-1088 |
 Dr. Mark Brennan, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Elks Point Rd, Zephyr Cove, NV 89448 Phone: 775-338-4145 Fax: 775-586-9019 |
Shahin Banayan Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Elks Point Rd, Zephyr Cove, NV 89448 Phone: 775-586-1088 Fax: 775-586-9019 |
Mr. Mikel Scott Ashby, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 Elks Point Rd, Zephyr Cove, NV 89448 Phone: 775-586-1088 Fax: 775-586-9019 |
News Archive
Prior Scientific's new ZDP50K translation stage compatible with all modern research microscopes
Providing a method to precisely move microscopes while allowing the sample to remain stationary, the new ZDP50K Translation Stage from Prior Scientific is compatible with all modern research microscopes.
There may be a real code to chromosomal organization
The identification of a cluster of essential genes on mouse chromosome 11 as well as similar clusters on the chromosomes of other organisms , including humans , buttresses the argument that there may be rules as to how genes are structured or laid out on chromosomes, said the Baylor College of Medicine senior author of a report that appears online in the Public Library of Science Genetics, an open-access publication.
Researchers discover blood clotting proteins in urine as biomarkers of lupus nephritis
University of Houston researcher Chandra Mohan is reporting in Arthritis Research and Therapy that clotting proteins, both those that promote blood clots (pro-thrombotic) and those that work to dissipate them (thrombolytic), are elevated in the urine of patients who suffer from lupus nephritis (LN).
Teva's DuoResp Spiromax receives EC marketing authorization for treatment of asthma, COPD
Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.
› Verified 3 days ago
Dentists
Pharmacists
Marriage Counselors
Psychologists
Counselors